Industrial Purity 6-Bromo-5-Fluoropicolinic Acid Coa Quality Assurance
- Verified Specifications: Molecular formula C6H3BrFNO2 with a molecular weight of 220.00 g/mol ensures stoichiometric accuracy.
- Quality Protocols: Rigorous HPLC and NMR verification protocols guarantee industrial purity standards above 98%.
- Supply Chain Security: Direct manufacturing capabilities support bulk procurement and custom synthesis requirements.
In the landscape of modern medicinal chemistry, the demand for reliable pharmaceutical raw materials is driven by the need for precise molecular architectures. 6-Bromo-5-fluoropicolinic acid serves as a critical intermediate in the development of kinase inhibitors and agrochemical agents. As a global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. prioritizes technical consistency and batch-to-batch reproducibility. This document outlines the technical specifications, quality assurance protocols, and manufacturing process controls required to maintain high standards for this heterocyclic compound.
Technical Specifications and Physicochemical Data
Understanding the fundamental properties of the molecule is essential for process chemists scaling up reactions. The compound, also known by its IUPAC name 6-bromo-5-fluoropyridine-2-carboxylic acid, possesses specific electronic properties due to the electron-withdrawing nature of the fluorine and carboxylic acid groups adjacent to the bromine substituent. These features influence reactivity in cross-coupling reactions such as Suzuki or Buchwald-Hartwig aminations.
| Parameter | Specification |
|---|---|
| Chemical Name | 6-Bromo-5-fluoropicolinic acid |
| CAS Registry Number | 1052714-46-1 |
| Molecular Formula | C6H3BrFNO2 |
| Molecular Weight | 220.00 g/mol |
| Purity Standard | >98.0% (HPLC Area %) |
| Appearance | Off-white to Light Yellow Crystalline Powder |
Accurate molecular weight data is crucial for calculating molar equivalents during reaction setup. Deviations in purity can lead to incomplete conversions or the formation of difficult-to-remove side products. Therefore, sourcing from a verified supplier is critical for maintaining process efficiency.
Comparing 98% vs 99% Purity Standards
In industrial applications, the distinction between 98% and 99% purity is not merely numerical; it represents significant differences in impurity profiles. For many fluorinated building blocks, the additional 1% purity often requires extensive recrystallization or chromatographic purification, which impacts the bulk price and lead time.
For most large-scale synthetic routes, a purity level of 98% is sufficient provided that the specific impurities are identified and controlled. However, for late-stage functionalization or sensitive catalytic processes, 99% purity may be required to prevent catalyst poisoning. At NINGBO INNO PHARMCHEM CO.,LTD., we analyze the specific impurity profile rather than relying solely on the total area percentage. This ensures that the industrial purity meets the specific needs of the downstream synthesis.
Synthesis Route and Impurity Control
The manufacturing process for this picolinic acid derivative typically involves the oxidation of the corresponding picoline or hydrolysis of a nitrile precursor. Controlling the reaction conditions is vital to prevent debromination or defluorination, which are common degradation pathways under harsh acidic or basic conditions.
Key impurities monitored during production include:
- Regioisomers: Presence of other bromo-fluoro isomers which can complicate purification.
- Starting Materials: Residual precursors that may carry through to the next step.
- Oxidation Byproducts: Over-oxidized species that alter the stoichiometry of subsequent reactions.
Effective impurity control relies on optimized reaction parameters and rigorous work-up procedures. When sourcing high-purity 6-Bromo-5-fluoropicolinic acid, buyers should request detailed impurity reports alongside the standard certificate of analysis. This transparency allows process teams to assess risk before integrating the material into their synthesis route.
HPLC and NMR COA Verification Protocols
Quality assurance is anchored in robust analytical data. A compliant Certificate of Analysis (COA) must include more than just a pass/fail status. It should provide chromatographic conditions and spectral data to verify identity and purity.
HPLC Verification
High-Performance Liquid Chromatography is the primary method for quantifying purity. Our protocols utilize reverse-phase columns with UV detection to separate the main peak from related substances. The method validation ensures linearity and accuracy across the expected concentration range.
NMR Confirmation
Proton and Fluorine NMR spectroscopy are employed to confirm the structural integrity of the heterocyclic compounds. The coupling constants between the fluorine atom and adjacent protons provide definitive evidence of the substitution pattern, distinguishing the 5-fluoro isomer from potential regioisomers.
Bulk Procurement and Commercial Considerations
Securing a stable supply chain for specialized intermediates requires a partner capable of scaling production without compromising quality. Market trends indicate fluctuating availability for halogenated pyridine derivatives due to regulatory changes in raw material sourcing. Established manufacturers mitigate this risk through vertical integration and strategic stockpiling of key precursors.
For procurement teams, evaluating a supplier involves assessing their capacity for custom synthesis and their ability to provide consistent COA documentation across multiple batches. Long-term contracts often stabilize pricing and ensure priority allocation during periods of high demand. By focusing on technical data and manufacturing capability rather than solely on initial cost, pharmaceutical companies can reduce the risk of production delays.
Conclusion
The reliability of 6-Bromo-5-fluoropicolinic acid in complex synthesis pathways depends on strict adherence to purity standards and comprehensive quality verification. Through advanced analytical protocols and controlled manufacturing processes, suppliers can deliver materials that meet the rigorous demands of modern drug discovery. Partnering with an experienced manufacturer ensures access to high-quality intermediates that support efficient and scalable chemical production.